Short Tandem Repeats (STR) Testing Market Size, Share and Global Trend By Kits (Y- short tandem repeats test kits, Short tandem repeats test kit, Mini- short tandem repeats test kit), End Users (Forensic laboratories, Research institutes) and Regional Forecast, 2024-2032

Short Tandem Repeats (STR) are the DNA regions with short repeat elements (usually 2-6 bp in length). Short tandem repeats are originated from the surroundings of chromosomal centromere (structural center of the chromosomes). Short tandem repeats have been demonstrated to have several benefits that make them completely suitable for human identification. Short Tandem Repeats analysis involves the extraction of nuclear DNA from cells in a sample, and certain regions of the DNA are later amplified with the help of the polymerase chain reaction technology.

Rise in the number of criminal cases combined with the increased rate of accidents leading to loss of memory, is subsequently leading to the increasing demand for the short tandem repeats testing for the detection of the identity of an individual. Also, increased investment in the research and development for genetic diseases and increasing investment healthcare and biotechnology companies are some of the major factors expected to drive the growth of the global short tandem repeats (STR) testing market during the forecast period 

The factors that are expected to inhibit the growth of the global short tandem repeats (STR) testing market are the production of artifacts during the amplification process, inability of the technique to distinguish between male relatives and the limitations of the haplotype frequency approach.

To gain extensive insights into the market, Request for Customization

Key Players Covered: 

Some of the major companies that are present in the global Short Tandem Repeats Testing market are Thermo Fisher Scientific, Promega Corporation., AB Sciex, Independent Forensics., General Electric, DNA Labs International, Inc., DNA Forensics Laboratory Pvt. Ltd., Hy Laboratories Ltd., Illumina, Inc., EasyDNA, Devyser, and others.

 SEGMENTATION

In 2018, cancer accounted for the largest share of the global short tandem repeats testing market, and is projected to continue dominance during the forecast period. Based on research study conducted by the Massachusetts Institute of Technology (MIT), out of projected 40 FDA-approved short tandem repeats testing products by 2022, around half are expected to be in the oncology space.

Key Insights

• Pipeline analysis


• The regulatory scenario for key countries


• Reimbursement scenario for key countries


• Key mergers and acquisitions


• Prevalence of diseases being treated by currently approved Short Tandem Repeats Testing products in key countries.

Regional Analysis:

Among the region, North America accounted for the largest share of the global short tandem repeats testing market in 2018. Increasing investment in the research and development and high demand for genetic counseling are factors driving the growth of the short tandem repeats testing market in the North America region. In the U.S., the 13-STR profile is a widely used means of identification, and this technology is now regularly employed to identify human remains, to establish or exclude paternity, or to match a suspect to a crime scene sample. Asia Pacific is expected to register a comparatively higher CAGR, due to the rising adoption of genetic testing methods, increasing R&D focus by market players, and increasing government funding for research activities.

Key Industry Developments

• In June 2018, NGeneBio launched IDaccuTest for its use in forensic testing, personal identification tests for family relationships and identification of paternity.


• In May 2018, Department of Forensic Medicine designed an innovative multiplex assay of SNP-STR markers for forensic use.


• In April 2018, Department of Forensic Science and DNA Services conducted a study on the analysis of mutation rate of 17 Y-chromosome short tandem repeats loci, which concluded that precise and reliable understanding of mutation rate at Y-chromosome short tandem repeats loci is required for a correct assessment and understanding of DNA typing results in forensics and paternity testing involving males.